No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis

BACKGROUND: The aim of this study is to assess the clinical benefit of postoperative radiotherapy (PORT) in patients with esophageal cancer (EC) who treated with neoadjuvant chemotherapy (NAC) and surgery via a national population-based database. METHODS: Patients diagnosed with EC between 2004 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Si-Yue, Qi, Wei-Xiang, Zhao, Sheng-Guang, Chen, Jia-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516333/
https://www.ncbi.nlm.nih.gov/pubmed/36185174
http://dx.doi.org/10.3389/fonc.2022.897476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516333/
https://www.ncbi.nlm.nih.gov/pubmed/36185174
http://dx.doi.org/10.3389/fonc.2022.897476

Ejemplares similares